ENDOMETRIAL MUCINOUS ADENOCARCINOMA
Clinical trials for ENDOMETRIAL MUCINOUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL MUCINOUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL MUCINOUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy duo shows promise against tough uterine cancer
Disease control Recruiting nowThis study is for people with a type of recurrent endometrial cancer that has a specific DNA repair problem (called dMMR). It compares a combination of two immunotherapy drugs (nivolumab and ipilimumab) against one drug alone (nivolumab) to see which shrinks tumors better. About …
Matched conditions: ENDOMETRIAL MUCINOUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Blood test may replace needle biopsies for endometrial cancer monitoring
Knowledge-focused Recruiting nowThis study is testing whether a blood test, called a liquid biopsy, can find cancer cells and predict if endometrial cancer will return. Researchers will collect blood and tissue samples from 1000 women with endometrial cancer before and after treatment. The goal is to see if thi…
Matched conditions: ENDOMETRIAL MUCINOUS ADENOCARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 09:02 UTC